Question 1

Does Centiva Capital own AMLX stock?

Accepted Answer

No. Centiva Capital exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 45,464 shares worth $291,424.

Question 2

How many shares of AMLX does Centiva Capital own?

Accepted Answer

None since Q3 2025, when Centiva Capital exited the position. Its Q2 2025 13F listed 45,464 shares worth $291,424.

Question 3

What is Centiva Capital's AMLX position worth?

Accepted Answer

Centiva Capital's AMLX position was worth $291,424 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Centiva Capital buying or selling AMLX?

Accepted Answer

In Q3 2025, Centiva Capital exited its entire AMLX position.

Question 5

When did Centiva Capital first buy AMLX?

Accepted Answer

Centiva Capital first reported AMLX in its Q4 2023 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$14.90	0
2025-Q2	Increased	45,464	+61.1%	$291,424	0.0%	$6.33	34
2025-Q1	Decreased	28,222	-16.6%	$99,906	0.0%	$3.66	0
2024-Q4	New	33,831	—	$127,881	0.0%	$3.84	31
2024-Q3	Exited	0	-100.0%	$0	0.0%	$3.08	0